Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site.
about
From kinetics and cellular cooperations to cancer immunotherapiesPD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression.[The vaccination-induced cooperation of T cells and myeloid cells leads to an anti-tumoral effect].The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression.Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.
P2860
Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Vaccine-induced tumor regressi ...... eloid cells at the tumor site.
@en
type
label
Vaccine-induced tumor regressi ...... eloid cells at the tumor site.
@en
prefLabel
Vaccine-induced tumor regressi ...... eloid cells at the tumor site.
@en
P2093
P2860
P50
P356
P1433
P1476
Vaccine-induced tumor regressi ...... yeloid cells at the tumor site
@en
P2093
Agnès Le Bon
Alain Trautmann
Bernett Lee
Estelle Dransart
Fabienne Regnier
HweiXian Leong Penny
Jean-Pierre Abastado
Julia Miriam Weiss
KarWai Tan
Nadège Bercovici
P2860
P304
27832-27846
P356
10.18632/ONCOTARGET.4940
P407
P577
2015-09-01T00:00:00Z